Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study

NeuroImage: Clinical

Volumn 7, Issue , 2015, Pages 34-42

  Pagani, M ^a,b   De Carli, F ^c   Morbelli, S ^d   Oberg J ^b   Chincarini, A ^e   Frisoni, G B ^f,g   Galluzzi, S ^f   Perneczky, R ^h,i,j   Drzezga, A ^j,m   Van Berckel, B N M ^k   Ossenkoppele, R ^k   Didic, M ^l   Guedj, E ^d   Brugnolo, A ^m   Picco, A ^m   Arnaldi, D ^m   Ferrara, M ^m   Buschiazzo, A ^d   Sambuceti, G ^d   Nobili, F ^d  

^a INSTITUTE OF COGNITIVE SCIENCES AND TECHNOLOGIES   (Italy)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c CNR   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e INFN SEZIONE DI GENOVA   (Italy)

^f IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^g UNIVERSITY OF GENEVA   (Switzerland)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁱ West London Cognitive Disorders Treatment and Research Unit   (United Kingdom)

^j TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^k VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^l AIX MARSEILLE UNIVERSITY   (France)

^m UNIVERSITY OF COLOGNE   (Germany)

more..

Author keywords

Discriminant analysis; EADC; FDG PET; MCI; Volume of interest

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CEREBELLUM; DIAGNOSTIC VALUE; DISCRIMINANT ANALYSIS; DRUG UPTAKE; FEMALE; FOLLOW UP; FRONTAL CORTEX; HEMISPHERE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; PARIETAL CORTEX; POSITRON; POSTERIOR CINGULATE; PRECUNEUS; SUPPORT VECTOR MACHINE; TEMPORAL CORTEX; VALIDATION STUDY; AGED; BRAIN; COMPUTER ASSISTED DIAGNOSIS; DISEASE COURSE; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SCINTISCANNING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; DISEASE PROGRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84911863288     PISSN: None     EISSN: 22131582     Source Type: Journal    
DOI: 10.1016/j.nicl.2014.11.007     Document Type: Article

References (66)

1. Albert M.S., DeKosky S.T., Dickson D., Dubois B., Feldman H.H., Fox N.C., Gamst A., Holtzman D.M., Jagust W.J., Petersen R.C., Snyder P.J., Carrillo M.C., Thies B., and Phelps C.H. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement. 7 3 2011 270 279 10.1016/j.jalz.2011.03.008 21514249
2. Anchisi D., Borroni B., Franceschi M., Kerrouche N., Kalbe E., Beuthien-Beumann B., Cappa S., Lenz O., Ludecke S., Marcone A., Mielke R., Ortelli P., Padovani A., Pelati O., Pupi A., Scarpini E., Weisenbach S., Herholz K., Salmon E., Holthoff V., Sorbi S., Fazio F., and Perani D. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease Arch. Neurol. 62 11 2005 1728 1733 10.1001/archneur.62.11.1728 16286547
3. Arbizu J., Prieto E., Martínez-Lage P., Martí-Climent J.M., García-Granero M., Lamet I., Pastor P., Riverol M., Gómez-Isla M.T., Peñuelas I., Richter J.A., and Weiner M.W. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia Eur. J. Nucl. Med. Mol. Imaging 40 9 2013 1394 1405 10.1007/s00259-013-2458-z 23715905
4. Bennett D.A., Wilson R.S., Schneider J.A., Evans D.A., Beckett L.A., Aggarwal N.T., Barnes L.L., Fox J.H., and Bach J. Natural history of mild cognitive impairment in older persons Neurology 59 2 2002 198 205 10.1212/WNL.59.2.198 12136057
5. Bloudek L.M., Spackman D.E., Blankenburg M., and Sullivan S.D. Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer's disease J. Alzheimers Dis. 26 4 2011 627 645 10.3233/JAD-2011-110458 21694448
6. 18F-FDG PET in the evaluation of dementia: a review of the recent literature J. Nucl. Med. 53 1 2012 59 71 10.2967/jnumed.111.096578 22173840
7. Brown L.D., Cai T.T., DasGupta A., Agresti A., Coull B.A., Casella G., Corcoran C., Mehta C., Ghosh M., Santner T.J., Brown L.D., Cai T.T., and DasGupta A. Interval estimation for a binomial proportion - comment - rejoinder Stat. Sci. 16 2 2001 101 133 10.1214/ss/1009213286
8. 18F-FDG PET: head-to-head comparison J. Nucl. Med. 53 4 2012 592 600 10.2967/jnumed.111.094946 22343502
9. Caselli R.J., Chen K., Lee W., Alexander G.E., and Reiman E.M. Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairment Arch. Neurol. 65 9 2008 1231 1236 10.1001/archneurol.2008.1 18779428
10. Chen K., Langbaum J.B., Fleisher A.S., Ayutyanont N., Reschke C., Lee W., Liu X., Bandy D., Alexander G.E., Thompson P.M., Foster N.L., Harvey D.J., de Leon M.J., Koeppe R.A., Jagust W.J., Weiner M.W., Reiman E.M. Alzheimer's Disease Neuroimaging Initiative Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative Neuroimage 51 2 2010 654 664 10.1016/j.neuroimage.2010.02.064 20202480
11. Chincarini A., Bosco P., Gemme G., Esposito M., Rei L., Squarcia S., Bellotti R., Minthon L., Frisoni G., Scheltens P., Frölich L., Soininen H., Visser P.J., and Nobili F. Automatic temporal lobe atrophy assessment in prodromal AD: data from the DESCRIPA study Alzheimers Dement 10 4 2014 456 467 10.1016/j.jalz.2013.05.1774 24035058
12. Cortes C., and Vapnik V. Support-Vector Networks Mach. Learn. 20 3 1995 273 297 10.1007/BF00994018
13. Cuingnet R., Gerardin E., Tessieras J., Auzias G., Lehéricy S., Habert M.O., Chupin M., Benali H., and Colliot O. Automatic classification of patients with Alzheimer's disease from structural MRI: a comparison of ten methods using the ADNI database Neuroimage 56 2 2011 766 781 10.1016/j.neuroimage.2010.06.013 20542124
14. De Santi S., de Leon M.J., Convit A., Tarshish C., Rusinek H., Tsui W.H., Sinaiko E., Wang G.-J., Bartlet E., and Volkow N. Age-related changes in brain: II. Positron emission tomography of frontal and temporal lobe glucose metabolism in normal subjects Psychiatr. Q. 66 4 1995 357 370 10.1007/BF02238755 8584591
15. Drzezga A., Lautenschlager N., Siebner H., Riemenschneider M., Willoch F., Minoshima S., Schwaiger M., and Kurz A. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study Eur. J. Nucl. Med. Mol. Imaging 30 8 2003 1104 1113 10.1007/s00259-003-1194-1 12764551
16. Dubois B., Feldman H.H., Jacova C., Cummings J.L., DeKosky S.T., Barberger-Gateau P., Delacourte A., Frisoni G., Fox N.C., Galasko D., Gauthier S., Hampel H., Jicha G.A., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Sarazin M., de Souza L.C., Stern Y., Visser P.J., and Scheltens P. Revising the definition of Alzheimer's disease: a new lexicon Lancet Neurol. 9 11 2010 1118 1127 10.1016/S1474-4422(10)70223-4 20934914
17. Dubois B., Feldman H.H., Jacova C., Dekosky S.T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Stern Y., Visser P.J., and Scheltens P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol. 6 8 2007 734 746 10.1016/S1474-4422(07)70178-3 17616482
18. Dubois B., Feldman H.H., Jacova C., Hampel H., Molinuevo J.L., Blennow K., DeKosky S.T., Gauthier S., Selkoe D., Bateman R., Cappa S., Crutch S., Engelborghs S., Frisoni G.B., Fox N.C., Galasko D., Habert M.O., Jicha G.A., Nordberg A., Pasquier F., Rabinovici G., Robert P., Rowe C., Salloway S., Sarazin M., Epelbaum S., de Souza L.C., Vellas B., Visser P.J., Schneider L., Stern Y., Scheltens P., and Cummings J.L. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria Lancet Neurol. 13 6 2014 614 629 10.1016/S1474-4422(14)70090-0 24849862
19. Dukart J., Kherif F., Mueller K., Adaszewski S., Schroeter M.L., Frackowiak R.S., and Draganski B. Generative FDG-PET and MRI model of aging and disease progression in Alzheimer's disease PLoS Comput. Biol. 9 4 2013 10.1371/journal.pcbi.1002987 23592957
20. Foster N.L., Heidebrink J.L., Clark C.M., Jagust W.J., Arnold S.E., Barbas N.R., DeCarli C.S., Turner R.S., Koeppe R.A., Higdon R., and Minoshima S. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease Brain 130 10 2007 2616 2635 10.1093/brain/awm177 17704526
21. Frisoni G.B., Bocchetta M., Chételat G., Rabinovici G.D., de Leon M.J., Kaye J., Reiman E.M., Scheltens P., Barkhof F., Black S.E., Brooks D.J., Carrillo M.C., Fox N.C., Herholz K., Nordberg A., Jack C.R. Jr., Jagust W.J., Johnson K.A., Rowe C.C., Sperling R.A., Thies W., Wahlund L.O., Weiner M.W., Pasqualetti P., and Decarli C. Imaging markers for Alzheimer disease: which vs how Neurology 81 5 2013 487 500 10.1212/WNL.0b013e31829d86e8 23897875
22. Friston K.J., Holmes A.P., Worsley K.J., Poline J.P., Frith C.D., and Frackowiak R.S.J. Statistical parametric maps in functional imaging: a general linear approach Hum. Brain Mapp. 2 4 1994 189 210 10.1002/hbm.460020402
23. Galluzzi S., Geroldi C., Ghidoni R., Paghera B., Amicucci G., Bonetti M., Zanetti O., Cotelli M., Gennarelli M., and Frisoni G.B. The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment J. Neurol. 257 12 2010 2004 2014 10.1007/s00415-010-5650-0 20632026
24. Gispert J.D., Pascau J., Reig S., Martínez-Lázaro R., Molina V., García-Barreno P., and Desco M. Influence of the normalization template on the outcome of statistical parametric mapping of PET scans Neuroimage 19 3 2003 601 612 10.1016/S1053-8119(03)00072-7 12880791
25. Glas A.S., Lijmer J.G., Prins M.H., Bonsel G.J., and Bossuyt P.M. The diagnostic odds ratio: a single indicator of test performance J Clin Epidemiol 56 11 2003 1129 1135 10.1016/S0895-4356(03)00177-X 14615004
26. Gray K.R., Wolz R., Heckemann R.A., Aljabar P., Hammers A., and Rueckert D. Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease Neuroimage 60 1 2012 221 229 10.1016/j.neuroimage.2011.12.071 22236449
27. Hanley J.A., and McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases Radiology 148 3 1983 839 843 10.1148/radiology.148.3.6878708 6878708
28. Herholz K. FDG PET and differential diagnosis of dementia Alzheimer Dis. Assoc. Disord. 9 1 1995 6 16 10.1097/00002093-199505000-00004 7605624
29. Herholz K., Salmon E., Perani D., Baron J.C., Holthoff V., Frölich L., Schönknecht P., Ito K., Mielke R., Kalbe E., Zündorf G., Delbeuck X., Pelati O., Anchisi D., Fazio F., Kerrouche N., Desgranges B., Eustache F., Beuthien-Baumann B., Menzel C., Schröder J., Kato T., Arahata Y., Henze M., and Heiss W.D. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET Neuroimage 17 1 2002 302 316 10.1006/nimg.2002.1208 12482085
30. Herholz K., Westwood S., Haense C., and Dunn G. Evaluation of a calibrated (18)F-FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairment J. Nucl. Med. 52 8 2011 1218 1226 10.2967/jnumed.111.090902 21764801
31. 18F-FDG PET imaging analysis for computer aided Alzheimer's diagnosis Inf. Sci. 181 4 2011 903 916 10.1016/j.ins.2010.10.027
32. Ishii K., Kono A.K., Sasaki H., Miyamoto N., Fukuda T., Sakamoto S., and Mori E. Fully automatic diagnostic system for early- and late-onset mild Alzheimer's disease using FDG PET and 3D-SSP Eur. J. Nucl. Med. Mol. Imaging 33 5 2006 575 583 10.1007/s00259-005-0015-0 16470370
33. Kakimoto A., Kamekawa Y., Ito S., Yoshikawa E., Okada H., Nishizawa S., Minoshima S., and Ouchi Y. New computer-aided diagnosis of dementia using positron emission tomography: brain regional sensitivity-mapping method PLoS ONE 6 9 2011 e25033 10.1371/journal.pone.0025033 21966405
34. Kovalev V.A., Thurfjell L., Lundqvist R., and Pagani M. Asymmetry of SPECT perfusion image patterns as a diagnostic feature for Alzheimer's disease Med. Image Comput. Comput. Assist. Interv. 9 2 2006 421 428 10.1007/11866763-52 17354800
35. Laforce R., Buteau J.P., Paquet N., Verret L., Houde M., and Bouchard R.W. The value of PET in mild cognitive impairment, typical and atypical/unclear dementias: a retrospective memory clinic study Am. J. Alzheimers Dis. Other Demen. 25 4 2010 324 332 10.1177/1533317510363468 20539026
36. Langbaum J.B., Chen K., Lee W., Reschke C., Bandy D., Fleisher A.S., Alexander G.E., Foster N.L., Weiner M.W., Koeppe R.A., Jagust W.J., and Reiman E.M. Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI) Neuroimage 45 4 2009 1107 1116 10.1016/j.neuroimage.2008.12.072 19349228
37. Lehman V.T., Carter R.E., Claassen D.O., Murphy R.C., Lowe V., Petersen R.C., and Peller P.J. Visual assessment versus quantitative three-dimensional stereotactic surface projection fluorodeoxyglucose positron emission tomography for detection of mild cognitive impairment and Alzheimer disease Clin. Nucl. Med. 37 8 2012 721 726 10.1097/RLU.0b013e3182478d89 22785496
38. Lemm S., Blankertz B., Dickhaus T., and Müller K.R. Introduction to machine learning for brain imaging Neuroimage 56 2 2011 387 399 10.1016/j.neuroimage.2010.11.004 21172442
39. Lucignani G., and Nobili F. FDG-PET for early assessment of Alzheimer's disease: isn't the evidence base large enough? Eur. J. Nucl. Med. Mol. Imaging 37 8 2010 1604 1609 10.1007/s00259-010-1535-9 20582541
40. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurol. 34 7 1984 939 944 10.1212/WNL.34.7.939 6610841
41. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., Klunk W.E., Koroshetz W.J., Manly J.J., Mayeux R., Mohs R.C., Morris J.C., Rossor M.N., Scheltens P., Carrillo M.C., Thies B., Weintraub S., and Phelps C.H. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement. 7 3 2011 263 269 10.1016/j.jalz.2011.03.005 21514250
42. Morbelli S., Drzezga A., Perneczky R., Frisoni G.B., Caroli A., van Berckel B.N., Ossenkoppele R., Guedj E., Didic M., Brugnolo A., Sambuceti G., Pagani M., Salmon E., and Nobili F. Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project Neurobiol. Aging 33 11 2012 2533 2550 10.1016/j.neurobiolaging.2012.01.005 22365486
43. Morbelli S., Perneczky R., Drzezga A., Frisoni G.B., Caroli A., van Berckel B.N., Ossenkoppele R., Guedj E., Didic M., Brugnolo A., Naseri M., Sambuceti G., Pagani M., and Nobili F. Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer Disease Consortium project J. Nucl. Med. 54 6 2013 894 902 10.2967/jnumed.112.113928 23591639
44. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD Eur. J. Nucl. Med. Mol. Imaging 32 4 2005 486 510 10.1007/s00259-005-1762-7 15747152
45. Mosconi L., Nacmias B., Sorbi S., De Cristofaro M.T., Fayazz M., Tedde A., Bracco L., Herholz K., and Pupi A. Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease J. Neurol. Neurosurg. Psychiatr. 75 3 2004 370 376 10.1136/jnnp.2003.014993 14966149
46. Mosconi L., Perani D., Sorbi S., Herholz K., Nacmias B., Holthoff V., Salmon E., Baron J.C., De Cristofaro M.T., Padovani A., Borroni B., Franceschi M., Bracco L., and Pupi A. MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET Neurology 63 12 2004 2332 2340 10.1212/01.WNL.0000147469.18313.3B 15623696
47. Mosconi L., Tsui W.H., Pupi A., De Santi S., Drzezga A., Minoshima S., and de Leon M.J. F-18-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease J. Nucl. Med. 48 7 2007 1129 1134 10.2967/jnumed.107.040675 17574982
48. Nobili F., Arnaldi D., Roccatagliata L., Chincarini A., Accardo J., Picco A., Ferrara M., Buschiazzo A., and Morbelli S. Neuroimaging findings in mild cognitive impairment R. Dierckx, O. de Vries, A. van Waarde, L. Kl, PET and SPECT in Neurology 2014 Springer-Verlag Berlin, Heidelberg 271 307
49. Nobili F., Salmaso D., Morbelli S., Girtler N., Piccardo A., Brugnolo A., Dessi B., Larsson S.A., Rodriguez G., and Pagani M. Principal component analysis of FDG PET in amnestic MCI Eur. J. Nucl. Med. Mol. Imaging 35 12 2008 2191 2202 10.1007/s00259-008-0869-z 18648805
50. Pagani M., Dessi B., Morbelli S., Brugnolo A., Salmaso D., Piccini A., Mazzei D., Villavecchia G., Larsson S.A., Rodriguez G., and Nobili F. MCI patients declining and not-declining at mid-term follow-up: FDG-PET findings Curr. Alzheimer Res. 7 4 2010 287 294 10.2174/156720510791162368 19939228
51. Pagani M., Salmaso D., Rodriguez G., Nardo D., and Nobili F. Principal component analysis in mild and moderate Alzheimer's disease - a novel approach to clinical diagnosis Psychiatry Res. 173 1 2009 8 14 10.1016/j.pscychresns.2008.07.016 19443186
52. Patterson J.C., Lilien D.L., Takalkar A., and Pinkston J.B. Early detection of brain pathology suggestive of early AD using objective evaluation of FDG-PET scans Int. J. Alzheimers Dis. 2011 2010 10.4061/2011/946590 20885966
53. Qin G.S., and Hotilovac L. Comparison of non-parametric confidence intervals for the area under the ROC curve of a continuous-scale diagnostic test Stat. Methods Med. Res. 17 2 2008 207 221 10.1177/0962280207087173 18426855
54. Ranginwala N.A., Hynan L.S., Weiner M.F., and White C.L. 3rd Clinical criteria for the diagnosis of Alzheimer disease: still good after all these years Am. J. Geriatr. Psychiatry 16 5 2008 384 388 10.1097/JGP.0b013e3181629971 18448850
55. Rodriguez G., Nobili F., De Carli F., Francione S., Marenco S., Celestino M.A., Hassan K., and Rosadini G. Regional cerebral blood flow in chronic stroke patients Stroke 24 1 1993 94 99 10.1161/01.STR.24.1.94 8418558
56. 18F-FDG PET images Med. Phys. 37 11 2010 6084 6095 10.1118/1.3488894 21158320
57. Schmahmann J.D., Doyon J., McDonald D., Holmes C., Lavoie K., Hurwitz A.S., Kabani N., Toga A., Evans A., and Petrides M. Three-dimensional MRI atlas of the human cerebellum in proportional stereotaxic space Neuroimage 10 3 Pt 1 1999 233 260 10.1006/nimg.1999.0459 10458940
58. Simel D.L., Samsa G.P., and Matchar D.B. Likelihood ratios with confidence: sample size estimation for diagnostic test studies J Clin Epidemiol 44 8 1991 763 770 10.1016/0895-4356(91)90128-V 1941027
59. Soonawala D., Amin T., Ebmeier K.P., Steele J.D., Dougall N.J., Best J., Migneco O., Nobili F., and Scheidhauer K. Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake Neuroimage 17 3 2002 1193 1202 10.1006/nimg.2002.1259 12414259
60. Sperling R.A., Aisen P.S., Beckett L.A., Bennett D.A., Craft S., Fagan A.M., Iwatsubo T., Jack C.R., Kaye J., Montine T.J., Park D.C., Reiman E.M., Rowe C.C., Siemers E., Stern Y., Yaffe K., Carrillo M.C., Thies B., Morrison-Bogorad M., Wagster M.V., and Phelps C.H. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement. 7 3 2011 280 292 10.1016/j.jalz.2011.03.003 21514248
61. Toussaint P.J., Perlbarg V., Bellec P., Desarnaud S., Lacomblez L., Doyon J., Habert M.O., and Benali H. Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer's disease using conjoint univariate and independent component analyses Neuroimage 63 2 2012 936 946 10.1016/j.neuroimage.2012.03.091 22510256
62. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., and Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain Neuroimage 15 1 2002 273 289 10.1006/nimg.2001.0978 11771995
63. 18F]FDG, version 2 Eur. J. Nucl. Med. Mol. Imaging 36 12 2009 2103 2110 10.1007/s00259-009-1264-0 19838705
64. Wahlund L.O., Barkhof F., Fazekas F., Bronge L., Augustin M., Sjögren M., Wallin A., Ader H., Leys D., Pantoni L., Pasquier F., Erkinjuntti T., and Scheltens P. A new rating scale for age-related white matter changes applicable to MRI and CT Stroke 32 6 2001 1318 1322 10.1161/01.STR.32.6.1318 11387493
65. Zahn R., Juengling F., Bubrowski P., Jost E., Dykierek P., Talazko J., and Huell M. Hemispheric asymmetries of hypometabolism associated with semantic memory impairment in Alzheimer's disease: a study using positron emission tomography with fluorodeoxyglucose-F18 Psychiatry Res 132 2 2004 159 172 10.1016/j.pscychresns.2004.07.006 15598550
66. Zhang D., Wang Y., Zhou L., Yuan H., and Shen D. Multimodal classification of Alzheimer's disease and mild cognitive impairment Neuroimage 55 3 2011 856 867 10.1016/j.neuroimage.2011.01.008 21236349